COA Certified · Every Batch TestedSame-Day Shipping on Orders by 2PM ESTUSA Sourced · USA ShippedFree Shipping on Orders Over $3004.9/5 from 2,400+ Verified Researchers≥99% Purity — HPLC + Mass SpecEndotoxin Tested · Sterility VerifiedCOA Certified · Every Batch TestedSame-Day Shipping on Orders by 2PM ESTUSA Sourced · USA ShippedFree Shipping on Orders Over $3004.9/5 from 2,400+ Verified Researchers≥99% Purity — HPLC + Mass SpecEndotoxin Tested · Sterility Verified
For Laboratory & Research Use Only — Not for Human or Veterinary Use
All ProductsGLP-1 & MetabolicResearch PeptidesPeptide BlendsNasal SpraysDissolving StripsBioregulatorsResearch BundlesLab SuppliesMerch Search

Semax Research: What the Studies Actually Show

Research-use-only context. This article summarizes published third-party scientific literature — the large majority of it conducted in cultured cells or animal models. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. American Peptides products are sold strictly for in vitro laboratory research and are not for human or veterinary use.

Semax has an unusually large research literature for a peptide, much of it from Russian institutions where it was developed. This summary surveys what the peer-reviewed studies report, what models they use, and where the human evidence stands by international standards. For the format used across this series, see our BPC-157 research review.

What semax is

Semax is a synthetic peptide based on a fragment of adrenocorticotropic hormone — the ACTH(4-7) sequence extended with a Pro-Gly-Pro tail (often written ACTH(4-7)PGP, an analog of the ACTH(4-10) region). It is studied for effects on the central nervous system without the hormonal (corticotropic) activity of full ACTH.

What the research reports

A substantial body of rat studies examines semax in cerebral ischemia (stroke) models. Genome-wide transcriptional analyses report effects on genes related to the immune and vascular systems in rat brain ischemia; a 2021 proteomics study reported a protective protein-expression profile in a rat ischemia-reperfusion model. More recent work extends to spinal-cord-injury models in mice (2025) and Alzheimer’s-disease animal models (2025), and some studies frame semax as a copper-chelating peptide that affects amyloid aggregation in artificial-membrane models. These findings are, with few exceptions, in rodents or cell systems.

The human-evidence gap

Semax is used clinically in Russia, but by Western regulatory standards it is not an FDA-approved drug, and large, independent, controlled human trials in the international literature are limited. The mechanistic weight of the evidence is rodent.

The takeaway

Semax has a deep, coherent preclinical literature in brain gene expression and neuroprotection models. Its regulatory status differs by country, and the internationally available human evidence is thin.

Frequently Asked Questions

What is semax derived from?

A fragment of adrenocorticotropic hormone — ACTH(4-7) with a Pro-Gly-Pro tail — studied for central-nervous-system effects without ACTH’s hormonal activity.

What models is semax studied in?

Predominantly rat models of cerebral ischemia (stroke), plus more recent mouse spinal-cord-injury and Alzheimer’s models.

Is semax approved by the FDA?

No. It is used clinically in Russia but is not FDA-approved. American Peptides supplies it strictly for in vitro research.

What pathways do semax studies focus on?

Brain gene- and protein-expression changes related to the immune and vascular systems, neurotrophic signaling, and metal-ion/amyloid interactions.

Citations

  1. Medvedeva EV, et al. “The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.” BMC Genomics. 2014. PubMed: PMID 24661604
  2. Stavchansky VV, et al. “Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion.” Int J Mol Sci. 2021. PubMed: PMID 34201112
  3. “Semax peptide targets the μ opioid receptor gene Oprm1 to promote functional recovery after spinal cord injury in female mice.” Br J Pharmacol. 2025. PubMed: PMID 40692165
  4. “Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Aβ Aggregation and Amyloid Formation in Artificial Membrane Models.” ACS Chem Neurosci. 2022. PubMed: PMID 35080861

Related reading: For the biology of focus, memory, and mental clarity behind this research — and how it all connects — see Why We Get Brain Fog: The Biology of Focus, Memory, and Mental Clarity.

This article is for laboratory research reference only. American Peptides products are sold strictly for in vitro research. Not for human consumption.


Compliance Notice: American Peptides products are sold strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.

← Back to the blog